Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5484514 | 0.98 | TSHR (0.31) | TSHR | |
| SCHEMBL27513560 | 0.77 | — | — | |
| SCHEMBL8384648 | 0.76 | LMNA (0.36) | — | |
| SCHEMBL8895999 | 0.76 | PBRM1 (0.35) | — | |
| SCHEMBL28101820 | 0.72 | TSHR (0.33) | TSHR | |
| SCHEMBL7632575 | 0.72 | TSHR (0.33) | TSHR | |
| SCHEMBL15247260 | 0.70 | — | — | |
| SCHEMBL19200939 | 0.70 | — | — | |
| SCHEMBL17073925 | 0.70 | — | — | |
| SCHEMBL28555639 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1966 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250387489-A1 | METHOD FOR PROVIDING A TOPICAL FORMULATION BASE | PEEP CLUB LTD (GB) | 2025-12-25 | — | — | US | claimed |
| US-20250332211-A1 | COMPOSITIONS FOR INHIBITING DEGRADATION OF HYALURONIC ACID AND METHODS OF USE THEREOF | EPIDARUS THERAPEUTICS LLC (US) | 2025-10-30 | — | — | US | claimed |
| US-12370231-B2 | Compositions for inhibiting degradation of hyaluronic acid and methods of use thereof | EPIDARUS THERAPEUTICS, LLC (US) | 2025-07-29 | — | — | US | claimed |
| EP-4565646-A2 | AQUEOUS SALT-FREE STABLE FLUID SUSPENSION COMPOSITIONS AND A METHOD OF PREPARATION THEREOF | Hercules LLC (US) | 2025-06-11 | — | — | EP | claimed |
| CN-112294975-B | Contact allergen reagent combination and uses thereof | 上海市皮肤病医院 | 2025-01-24 | — | — | CN | claimed |
| WO-2024102364-A1 | SYSTEM AND METHOD FOR REMOTE SCREENING AND DIAGNOSIS OF CONTACT ALLERGIES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-05-16 | — | — | WO | claimed |
| US-20240148635-A1 | COSMETIC COMPOSITIONS COMPRISING POLYETHER POLYMERS | P2 SCIENCE, INC. | 2024-05-09 | — | — | US | claimed |
| WO-2024030783-A2 | AQUEOUS SALT-FREE STABLE FLUID SUSPENSION COMPOSITIONS AND A METHOD OF PREPARATION THEREOF | HERCULES LLC (US) | 2024-02-08 | — | — | WO | claimed |
| US-11883453-B2 | Formulation based on medicinal plant, or part or extract thereof, use of the formulation and product including said formulation | PHYTOPLENUS BIOATIVOS S.A (BR) | 2024-01-30 | — | — | US | claimed |
| US-11872300-B2 | Cosmetic compositions comprising polyether polymers | P2 SCIENCE, INC. (US) | 2024-01-16 | — | — | US | claimed |
| EP-1221313-A9 | Salts of undecylenoyl glutamate or of undecylenoyl hydrolyzate of wheat or rice proteins in detergent or cosmetic compositions | Zschimmer & Schwarz Italiana S.p.A. (IT) | 2003-01-02 | — | — | EP | claimed |
| EP-1221313-A2 | Salts of undecylenoyl glutamate or of undecylenoyl hydrolyzate of wheat or rice proteins in detergent or cosmetic compositions | Zschimmer & Schwarz Italiana S.p.A. (IT) | 2002-07-10 | — | — | EP | claimed |
| US-20020028754-A1 | Antimicrobial compositions | NOVOZYMES A/S (DK) | 2002-03-07 | — | — | US | claimed |
| WO-2002008377-A1 | ANTIMICROBIAL COMPOSITIONS | NOVOZYMES A/S (DK) | 2002-01-31 | — | — | WO | claimed |
| EP-0766557-B1 | TOPICAL COMPOSITIONS COMPRISING N-ACETYL-L-CYSTEINE | PROCTER & GAMBLE (US) | 2001-12-19 | — | — | EP | claimed |
| CN-1070699-C | Topical compositions comprising N-acetyl-L-cysteine | PROCTER & GAMBLE (US) | 2001-09-12 | — | — | CN | claimed |
| US-6231849-B1 | HUNTING | Schiller, George A. | 2001-05-15 | — | — | US | claimed |
| EP-1074247-A2 | Cleansing or cosmetic compositions comprising zinc alkylsulphates and/or alky(poly)ethoxysulphates as surfactants and preservatives | Zschimmer & Schwarz Italiana S.p.A. (IT) | 2001-02-07 | — | — | EP | claimed |
| US-5716635-A | Plantago major transdermal patch for use in treating a tobacco or nicotine habit | M. E. CODY PRODUCTS, INC. (US) | 1998-02-10 | — | — | US | claimed |
| EP-0598412-A2 | Skinprotection composition | MEDICON GESELLSCHAFT FÜR UNTERNEHMENSBERATUNG IM BEREICH MEDIZIN UND GESUNDHEITSWESEN mbH (DE) | 1994-05-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240148635-A1 | COSMETIC COMPOSITIONS COMPRISING POLYETHER POLYMERS | CUTA, LAGE3, POLR1C | TSHR 2071/4885 |
| US-11872300-B2 | Cosmetic compositions comprising polyether polymers | CUTA, LAGE3, POLR1C | TSHR 2071/4885 |
| US-20250387489-A1 | METHOD FOR PROVIDING A TOPICAL FORMULATION BASE | VEGFA, AQP3, DSG1 | TSHR 3688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.